Patents by Inventor Phillip Parsons

Phillip Parsons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8794694
    Abstract: A foot isolation platform for a vehicle includes a base for connection with the vehicle floor to be movable with the vehicle floor; a foot support movable relative to the base and having an upper surface for supporting the feet of the vehicle occupant above the base; and an isolation member connected in a force-transmitting relationship between the base and the foot support. The isolation member supports the foot support in an extended position above the base. The isolation member acts to isolate the foot support from the vehicle floor in the event of rapid upward movement of the vehicle floor thereby to help protect the lower extremities of the vehicle occupant.
    Type: Grant
    Filed: November 16, 2012
    Date of Patent: August 5, 2014
    Assignee: BAE Systems Aerospace & Defense Group Inc.
    Inventors: Curtis Phillip Parsons, Gregory Alan Mowry
  • Patent number: 8146988
    Abstract: A vehicle seat that strokes during an energy absorption process is able to reset. The seat can therefore stroke again, in the same stroking volume, for example during a secondary ground impact after a mine blast. An energy absorber associated with the seat is operative to absorb energy once during the first stroke and is also operative to absorb energy a second time when the seat strokes a second time.
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: April 3, 2012
    Assignee: BAE Systems Aerospace & Defense Group Inc.
    Inventors: Gregory Alan Mowry, Marvin Kent Richards, Gregory Brian Grace, Curtis Phillip Parsons
  • Publication number: 20120015947
    Abstract: A compound of formula (I): in which— X represents O or CH2; R3 and R4 each independently represent hydrogen or C1-6 alkyl; p represent 0 or 1; and R represents a five- or six-membered saturated or unsaturated ring selected from: or R represents a five- or six-membered oxo-substituted unsaturated ring selected from: wherein R1 and R2 together represent an oxo group, or R1 and R2 each represent hydrogen, methoxy or ethoxy, or R1 and R2 together with the interjacent carbon atom represent a 1,3-dioxolane or 1,3-dioxane ring, attached via the 2 position and optionally bearing one or more methyl or ethyl groups; or a salt thereof, is suitable for the treatment of anxiety and depression.
    Type: Application
    Filed: August 5, 2011
    Publication date: January 19, 2012
    Applicant: BTG International Limited
    Inventors: Phillip Parsons, Silvia Trasciatti, Sergio Rosini, Michael Annis
  • Patent number: 8053432
    Abstract: A compound of formula (I): in which X represents O or CH2; R3 and R4 each independently represent hydrogen or C1-6 alkyl; p represent 0 or 1; and R represents a five- or six-membered saturated or unsaturated ring selected from: formula (II), (III) and (IV); or R represents a five- or six-membered oxo-substituted unsaturated ring selected from: (V) and (VI); wherein R1 and R2 together represent an oxo group, or R1 and R2 each represent hydrogen, methoxy or ethoxy, or R1 and R2 together with the interjacent carbon atom represent a 1,3-dioxolane or 1,3-dioxane ring, attached via the 2 position and optionally bearing one or more methyl or ethyl groups; or a salt thereof, is suitable for the treatment of anxiety and depression.
    Type: Grant
    Filed: June 15, 2010
    Date of Patent: November 8, 2011
    Assignee: BTG International Limited
    Inventors: Phillip Parsons, Silvia Trasciatti, Sergio Rosini, Michael Annis
  • Patent number: 7842690
    Abstract: A compound of formula (I): in which X represents O or CH2; R3 and R4 each independently represent hydrogen or C1-6 alkyl; p represent 0 or 1; and R represents a five- or six-membered saturated or unsaturated ring selected from: formula (II), (III) and (IV); or R represents a five- or six-membered oxo-substituted unsaturated ring selected from: (V) and (VI); wherein R1 and R2 together represent an oxo group, or R1 and R2 each represent hydrogen, methoxy or ethoxy, or R1 and R2 together with the interjacent carbon atom represent a 1,3-dioxolane or 1,3-dioxane ring, attached via the 2 position and optionally bearing one or more methyl or ethyl groups; or a salt thereof, is suitable for the treatment of anxiety and depression.
    Type: Grant
    Filed: August 18, 2009
    Date of Patent: November 30, 2010
    Assignee: BTG International Limited
    Inventors: Phillip Parsons, Silvia Trasciatti, Sergio Rosini, Michael Annis
  • Patent number: 7842689
    Abstract: A compound of formula (II): in which— R3 and R4 each independently represent hydrogen or C1-6 alkyl; p represent 0 or 1; and R represents a five- or six-membered saturated or unsaturated ring selected from: R represents a five- or six-membered substituted or unsubstituted unsaturated ring selected from: wherein R1 and R2 together represent an oxo group, or R1 and R2 each represent hydrogen, methoxy or ethoxy, or R1 and R2 together with the interjacent carbon atom represent a 1,3-dioxolane or 1,3-dioxane ring, attached via the 2 position and optionally bearing one or more methyl or ethyl groups; or a salt thereof, which is suitable for the treatment of anxiety and depression.
    Type: Grant
    Filed: June 1, 2004
    Date of Patent: November 30, 2010
    Assignee: BTG International Limited
    Inventors: Phillip Parsons, Silvia Trasciatti, Sergio Rosini, Michael Annis
  • Publication number: 20100270836
    Abstract: A vehicle seat that strokes during an energy absorption process is able to reset. The seat can therefore stroke again, in the same stroking volume, for example during a secondary ground impact after a mine blast. An energy absorber associated with the seat is operative to absorb energy once during the first stroke and is also operative to absorb energy a second time when the seat strokes a second time.
    Type: Application
    Filed: April 28, 2009
    Publication date: October 28, 2010
    Applicant: BAE Systems Aerospace and Defense Group Inc.
    Inventors: Gregory Alan Mowry, Marvin Kent Richards, Gregory Brian Grace, Curtis Phillip Parsons
  • Publication number: 20100256150
    Abstract: A compound of formula (I): in which X represents O or CH2; R3 and R4 each independently represent hydrogen or C1-6 alkyl; p represent 0 or 1; and R represents a five- or six-membered saturated or unsaturated ring selected from: formula (II), (III) and (IV); or R represents a five- or six-membered oxo-substituted unsaturated ring selected from: (V) and (VI); wherein R1 and R2 together represent an oxo group, or R1 and R2 each represent hydrogen, methoxy or ethoxy, or R1 and R2 together with the interjacent carbon atom represent a 1,3-dioxolane or 1,3-dioxane ring, attached via the 2 position and optionally bearing one or more methyl or ethyl groups; or a salt thereof, is suitable for the treatment of anxiety and depression.
    Type: Application
    Filed: June 15, 2010
    Publication date: October 7, 2010
    Applicant: BTG International Limited
    Inventors: Phillip Parsons, Silvia Trasciatti, Sergio Rosini, Michael Annis
  • Publication number: 20090312329
    Abstract: A compound of formula (I): in which X represents O or CH2; R3 and R4 each independently represent hydrogen or C1-6 alkyl; p represent 0 or 1; and R represents a five- or six-membered saturated or unsaturated ring selected from: formula (II), (III) and (IV); or R represents a five- or six-membered oxo-substituted unsaturated ring selected from: (V) and (VI); wherein R1 and R2 together represent an oxo group, or R1 and R2 each represent hydrogen, methoxy or ethoxy, or R1 and R2 together with the interjacent carbon atom represent a 1,3-dioxolane or 1,3-dioxane ring, attached via the 2 position and optionally bearing one or more methyl or ethyl groups; or a salt thereof, is suitable for the treatment of anxiety and depression.
    Type: Application
    Filed: August 18, 2009
    Publication date: December 17, 2009
    Applicant: BTG International Limited
    Inventors: Phillip Parsons, Silvia Trasciatti, Sergio Rosini, Michael Annis
  • Publication number: 20060142286
    Abstract: A compound of formula (I): in which X represents O or CH2; R3 and R4 each independently represent hydrogen or C1-6 alkyl; p represent 0 or 1; and R represents a five- or six-membered saturated or unsaturated ring selected from: formula (II), (III) and (IV); or R represents a five- or six-membered oxo-substituted unsaturated ring selected from: (V) and (VI); wherein R1 and R2 together represent an oxo group, or R1 and R2 each represent hydrogen, methoxy or ethoxy, or R1 and R2 together with the interjacent carbon atom represent a 1,3-dioxolane or 1,3-dioxane ring, attached via the 2 position and optionally bearing one or more methyl or ethyl groups; or a salt thereof, is suitable for the treatment of anxiety and depression.
    Type: Application
    Filed: June 1, 2004
    Publication date: June 29, 2006
    Inventors: Phillip Parsons, Silvia Trasciatti, Sergio Rosini, Michael Annis